Rigel Pharmaceuticals, Inc. (RIGL) Cash Flow Statement
Rigel Pharmaceuticals, Inc. (RIGL) generated $79.4M of operating cash flow over the twelve months to 2026-06-30, spent $0 on capital expenditure and had free cash flow of $79.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RIGLRigel Pharmaceuticals, Inc.Follow RIGL — free
—
Price chart with a free account
- Market cap
- 899.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -58.8 | -41.5 | -52.2 | 5.9 | -73.8 | -5.7 | 31.5 | 75.7 | 79.4 | |
| Capital expenditure | 1.1 | 1.5 | 1.3 | 0.6 | 0.5 | 0.0 | 0.0 | 0.0 | -0.0 | |
| Free cash flow | -59.9 | -43.0 | -53.4 | 5.3 | -74.2 | -5.7 | 31.4 | 75.7 | 79.4 | |
| Stock-based compensation | 7.7 | 9.1 | 7.3 | 9.5 | 12.4 | 8.8 | 12.4 | 12.7 | — |
USD millions · SEC XBRL
Rigel Pharmaceuticals, Inc. — questions
- What is Rigel Pharmaceuticals, Inc.'s operating cash flow?
- $79.4M over the twelve months to 2026-06-30.
- How much does Rigel Pharmaceuticals, Inc. spend on capital expenditure?
- $0 over the twelve months to 2026-06-30.
- What is Rigel Pharmaceuticals, Inc.'s free cash flow?
- $79.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Rigel Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.